New York State Common Retirement Fund Avidity Biosciences, Inc. Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 392,644 shares of RNA stock, worth $27.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
392,644
Previous 272,279
44.21%
Holding current value
$27.8 Million
Previous $7.73 Million
121.25%
% of portfolio
0.02%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding RNA
# of Institutions
311Shares Held
139MCall Options Held
1.24MPut Options Held
526K-
Janus Henderson Group PLC London, X014.5MShares$1.03 Billion0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$936 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY11.4MShares$805 Million6.62% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$713 Million0.08% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.79MShares$693 Million0.05% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $3.69B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...